Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects

Schizophrenia Research

Volumn 100, Issue 1-3, 2008, Pages 356-358

  Friedman, Joseph I ^a,b   Chang, Linda ^c   Ernst, Thomas ^c   Tsopelas, Nicholas D ^d   Zhong, Kai ^e   Davis, Kenneth L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Pilgrim Psychiatric Center   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; COGNITION; ETHNICITY; FEMALE; FUNCTIONAL STATUS; HUMAN; LETTER; MALE; MENTAL DISEASE; MENTAL PATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SKILL; SOCIAL INTERACTION; WHITE MATTER;

AGE FACTORS; AGED; BRAIN DISEASES, METABOLIC; COGNITION DISORDERS; COMORBIDITY; CONTROL GROUPS; EDUCATIONAL STATUS; FUNCTIONAL LATERALITY; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT;

EID: 39849083779     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.10.006     Document Type: Letter

References (10)

1. Auer D.P., Wilke M., Grabner A., Heidenreich J.O., Bronisch T., and Wetter T.C. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation. Schizophr. Res. 52 1-2 (2001) 87-99
2. Chang L., Friedman J., Ernst T., Zhong K., Tsopelas N.D., and Davis K. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol. Psychiatry (2007) [Aug 10; Epub ahead of print]
3. Friedman J.I., Harvey P.D., Coleman T., Moriarty P.J., Bowie C., Parrella M., White L., Adler D., and Davis K.L. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am. J. Psychiatry 158 (2001) 1441-1448
4. Kay S.R. Positive and Negative Syndromes in Schizophrenia (1991), Brunner/Mazel, New York
5. Heresco-Levy U., Ermilov M., Shimoni J., Shapira B., Silipo G., and Javitt D.C. Placebo-controlled trial of d-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Am. J. Psychiatry 159 3 (2002) 480-482
6. Hof P.R., Haroutunian V., Friedrich Jr. V.L., Byne W., Buitron C., Perl D.P., and Davis K.L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 53 12 (2003) 1075-1085
7. Javitt D.C., Silipo G., Cienfuegos A., Shelley A.M., Bark N., Park M., Lindenmayer J.P., Suckow R., and Zukin S.R. Adjunctive high-dose glycine in the treatment of schizophrenia. Int. J. Neuropsychopharmacol 4 4 (2001) 385-391
8. Schneider L.C., and Streuening E.L. SLOF: a behavioral rating scale for assessing the mentally ill. Soc. Work Res. Abstr. 6 (1983) 9-21
9. Sigmundsson T., Maier M., Toone B.K., Williams S.C., Simmons A., Greenwood K., and Ron M.A. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr. Res. 64 1 (2003) 63-71
10. Tang C.Y., Friedman J., Shungu D., Chang L., Ernst T., Stewart D., Hajianpour A., Carpenter D., Ng J., Mao X., Hof P.R., Buchsbaum M.S., Davis K., and Gorman J.M. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry 7 (2007) 25 [Jun 19]